incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

PETALING JAYA: Pharmaceutical firm Novartis Malaysia has set up a hybrid office in Plaza Imazium, Damansara Uptown, as part of its strategic growth strategy and commitment to future-proof its ...

Marlborough, Massachusetts--(Newsfile Corp. - January 15, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics using its INTASYL ...

Registration Link for Presentation and live Q&A to take place, Tuesday February 4, 2025 at 2:00 pm EST Marlborough, Massachusetts--(Newsfile Corp. - February 3, 2025) - Phio Pharmaceuticals Corp ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Novartis Pharmaceuticals Corp. accused generics-maker MSN Pharmaceuticals Inc. of planning a “scheme designed to confuse consumers” over the source of its “Novadoz” version of the blockbuster heart ...

FRANKFURT, Jan 31 (Reuters) - The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization and related programmes risks harming ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

a generic version of Novartis Pharmaceutical Corporation’s Afinitor Disperz. Marketing partner for its abbreviated new drug application (ANDA), Breckenridge Pharmaceutical Inc., plans to launch ...

Natco Pharma announced approval of its ANDA for Everolimus tablets for oral suspension (TFOS), 2mg, 3mg and 5mg, a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation. NATCO's ...